MedPath

Long Term Results in Hypoplastic Aortic Arch Repair in Neonates Using a Glutaraldehyde Treated Autologous Pericardial Patch

Conditions
Congenital Hypoplasia of Aortic Arch
Registration Number
NCT03588312
Lead Sponsor
Queen Fabiola Children's University Hospital
Brief Summary

Hypoplastic aortic arch is a congenital heart defect that is prejudicial for the growth of newborns. It is often associated to other heart defects. Different surgical techniques exist to address this defect, but the literature is very poor with regards to the use of an autologous pericardial patch. Most use extensive dissection techniques or synthetic patches. Here investigators report institution's original approach using the newborns own pericardium for what investigators believe to be an optimal correction of the hypoplasia., with preserved growth potential.

Detailed Description

Retrospective analysis of an already well codified surgical intervention carried out in HUDERF under extra-corporeal circulation

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Newborns with a hypoplastic aortic arch undergoing a first intervention
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival30 days post surgery
Secondary Outcome Measures
NameTimeMethod
Freedom from re-interventionUp to 18 years post initial surgery

Trial Locations

Locations (1)

Hôpital Universitaire Des Enfants Reine Fabiola

🇧🇪

Brussels, Belgium

Hôpital Universitaire Des Enfants Reine Fabiola
🇧🇪Brussels, Belgium
Pierre Wauthy, MD PhD
Principal Investigator
Louis Chebli, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.